info iconCurrently, the share price for Biocon Ltd. is delayed.

close icon
Biocon Ltd. Logo

Biocon Ltd.

₹375.35
NSE
--   ( -- %) 1D



  • Prev. Close
    375.35
  • Upper Circuit
    412.85
  • Lower Circuit
    337.85

Analyst Sentiment For Biocon Ltd.

Info icon
As recommended by 16 analysts
Created with Highcharts 7.2.225 %25 %25 %25 %50 %50 %PositiveNeutralNegative

Returns

Created with Highcharts 7.2.21015.00%1015.00%1167.00%1167.00%273.00%273.00%5423.00%5423.00%20.58%20.58%2964.67%2964.67%1 Week1 Month3 Months1 Year3 Year5 Year

Biocon Ltd.'s Info & Management

Biocon Limited, India’s largest fully integrated, innovation-led biopharmaceutical company based in Bengaluru, specialises in the treatment of diabetes, cancer, and autoimmune diseases. Biocon was incorporated in 1978. Its business segments encompass Generics, Biosimilars, Novel Biologics, and Research Services.


It has developed and commercialised novel biologics, biosimilars, and complex small molecule active pharmaceutical ingredients (APIs) in India and numerous global markets. Additionally, its Generic Formulations serve the United States, Europe, and key emerging markets.


Its API portfolio covers cardiovascular, anti-diabetics, immunosuppressants, multiple sclerosis, anti-fungal and other key products. The products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others.


It has over five R&D and manufacturing facilities across Bangalore, Hyderabad and Visakhapatnam in India. The API manufacturing facilities leverage its complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.


The company’s subsidiaries include Biocon Academy in India, Biocon Pharma Limited in India, Biocon Biologics Limited in India, Biocon FZ LLC in the UAE, and several others.

  • Group Chief Executive Officer
    Peter John Bains
  • Company Secretary,Compliance Officer
    MAYANK VERMA
  • Chief Commercial Officer
    Abhijit Zutshi
  • Chief Scientific Officer
    Manoj Kumar Pananchukunnath
  • Chief Operating Officer
    Arun Kumar Gupta
  • Head(Human Resources)
    Maninder Kapoor Puri

FAQs on Biocon Ltd.

What is the share price of Biocon Ltd.?

Biocon Ltd. share price is ₹374.50 as of December 2, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Biocon Ltd.?

The 52-week high and low of Biocon Ltd. is ₹395.55 and ₹237.00 respectively as of December 2, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Biocon Ltd.?

The trailing twelve month (TTM) PB ratio of Biocon Ltd. is 2.22 as of December 3, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Biocon Ltd.?

The Upper Circuit of Biocon Ltd. is ₹413. The Lower Circuit of Biocon Ltd. is ₹338.

What is the ROE of Biocon Ltd.?

Biocon Ltd. reported an ROE of 5.43% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Biocon Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Biocon Ltd., Promoter held 60.6%, the FII held 5.9%, DII held 14.4% and the public held 18.7% of the total shares.

How to buy Biocon Ltd. Share?

You can easily buy shares of Biocon Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Biocon Ltd.?

The fair value of Biocon Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer